Generate Biomedicines, Inc. (GENB)

CIK 2100782 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Generate Biomedicines, Inc..

Recent SEC filings

FiledFormAccession number
Sep 3, 202640001193125-26-381875
Sep 2, 20261440001959173-26-006666
Sep 1, 20261440001959173-26-006611
Aug 26, 20268-K0001193125-26-365556
Aug 6, 202610-Q0001193125-26-336437
Aug 6, 20268-K0001193125-26-336462
May 15, 2026SCHEDULE 13G0001193125-26-225441
May 15, 2026SCHEDULE 13G0001193125-26-226574
May 7, 202610-Q0001193125-26-210059
May 7, 20268-K0001193125-26-209899
Mar 12, 202630000950130-26-000106
Mar 6, 202640001193125-26-096799
Mar 2, 202640001193125-26-085911
Mar 2, 202640001193125-26-085861
Mar 2, 202640001193125-26-085855
Mar 2, 202640001193125-26-085872
Mar 2, 202640001193125-26-085939
Mar 2, 202640001193125-26-085952
Mar 2, 202640001193125-26-085886
Mar 2, 202640001193125-26-085903
Mar 2, 202640001193125-26-085898
Mar 2, 20268-K0001193125-26-085780
Mar 2, 202640001193125-26-085888
Mar 2, 202640001193125-26-085910
Mar 2, 202640001193125-26-085881